Aft Pharmaceuticals Is A New Zealand Based Multinational Pharmaceutical Company Founded In 1997 By Drhartley Atkinson And Marree Atkinsonheadquartered In Takapunaaucklandaft Has Expanded From A Small Operation To A Publicly Listed Company With A Market Capitalization Of Approximately Nz$250 Million As Of 2017 And Reported Revenue Of $180 Million In 2024The Company Operates Offices In Aucklandsydneykuala Lumpurand Singaporeexporting Or Licensing Products To Over 109 Countries Aft Specializes In Niche Pharmaceutical Opportunitiesfocusing On In House Research And Development As Well As Global Partnerships To Create Innovative Treatmentsthe Company Offers Over 130 Prescription And Over The Counter Productsincluding Its Flagship Combination Analgesicmaxigesica Which Is Licensed In 124 Countriesaft Also Engages In Drug Developmentholds Global Patents For Proprietary Formulationsand Collaborates With International Partners For Clinical Trials And Distributionits Mission Includes Providing Accessible Pharmaceuticalssupported By Initiatives Like The Orphan Drugs Foundationwhich Offers Low Cost Medications For Rare Diseases In Southeast Asia And The Pacific
